Last reviewed · How we verify

NCT04936555

The Effect of Self-Acupressure Application on Functional Composite and Quality of Life in Multiple Sclerosis Patients

Completed NA Last updated 22 July 2021
What this trial tests

NA trial testing Self-Acupressure in Multiple Sclerosis in 60 participants. Completed in 15 July 2021.

Timeline
1 May 2021
Primary endpoint
1 June 2021
15 July 2021

Quick facts

Lead sponsorIstanbul Sabahattin Zaim University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposesupportive care
Enrollment60
Start date1 May 2021
Primary completion1 June 2021
Estimated completion15 July 2021
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Istanbul Sabahattin Zaim University

Who can join

Adults 18 to 65, any sex, with Multiple Sclerosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

It is important to consider the functional composite and quality of life of patients with multiple sclerosis (MS) and to plan interventions for these problems.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Self-Acupressure

Trials testing the same drug.

Other recruiting trials for Multiple Sclerosis

Currently open trials in the same condition.

Other Istanbul Sabahattin Zaim University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04936555.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing